Topic: Ozempic

Lawsuits are emerging against the makers of Ozempic and other GLP-1 drugs, alleging they can cause "NAION," a condition that leads to sudden and permanent blindness. One patient, Todd Engel, lost vision in both eyes after taking the drug for diabetes, a side effect he claims was not properly disclosed. Medical research has recently indicated a higher rate of optic neuropathy among diabetic patients using these weight-loss medications.

Andrew Horowitz and Adam Curry discuss the side effects of GLP-1 weight loss drugs, specifically the loss of muscle mass in older patients. Horowitz shares an "off-stage" comment from a chief medical officer regarding an increase in falls and injuries among users. Horowitz maintains that he has avoided muscle loss by working out three days a week while using the medication.

Pharmaceutical companies Novo Nordisk and Eli Lilly face lawsuits alleging that GLP-1 drugs like Ozempic cause a rare type of vision loss. The hosts discuss the widespread use of these drugs for weight loss and the growing trend of "micro-dosing" peptides and Botox among social circles. They express skepticism regarding the long-term safety of these treatments and the "aesthetics" culture driving their popularity.

Megyn Kelly criticized Caitlin Clark for not taking a stronger public stance on the transgender issue in sports. The hosts discuss the pressure on celebrities to engage in political "pot-stirring." They also touch on the physical appearance of Ariana Grande and the concept of "digitally induced autism" caused by excessive childhood tablet use.

The deep state and the pharmaceutical industry are described as an unbreakable alliance that influences federal policy. Robert F. Kennedy Jr. previously pledged to ban television advertising for pharmaceuticals, a practice currently legal only in the United States and New Zealand. The hosts argue these advertisements undermine the relationship between doctors and patients.